Foamix Investigational Site #244 — Encino, California

Foamix Investigational Site #244 is a clinical research site located in Encino, California, United States 91436.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Foamix Investigational Site #244 has participated in 1 clinical trials.

Therapeutic areas: Facial Papulopustular Rosacea.

Sponsors: Vyne Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Encino

Browse all research sites in California · View every site in Encino

• The University of California, Los Angeles
• Encino Hospital Medical Center
• The Retina Partners
• Pharmacology Research Institute
• Research Site
• Encino Research Center
• Novo Nordisk Investigational Site
• T Joseph Raoof Md Inc
• WR-PRI
• HRC Fertility
• Pfizer Investigational Site
• Clinical Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Foamix Investigational Site #244?

Foamix Investigational Site #244 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Foamix Investigational Site #244 conducted?

Foamix Investigational Site #244 has 1 clinical trials on record. Their work covers Facial Papulopustular Rosacea.

Is Foamix Investigational Site #244 accredited by Crixeo Clinical Trials?

Foamix Investigational Site #244 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Foamix Investigational Site #244?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.